1. International Agency for Research on Cancer. World Health Organization. GLOBOCAN 2020: Global Cancer Observatory, Cancer Today [Internet] Lyon: International Agency for Research on Cancer; 2021 [cited 2021 Jul 14]. Available from:
http://gco.iarc.fr/today
.
2. Park S, Oh CM, Cho H, Lee JY, Jung KW, Jun JK, et al. Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study. BMJ 2016;355:i5745.
[CROSSREF] [PUBMED] [PMC]
3. Liu Y, Su L, Xiao H. Review of factors related to the thyroid cancer epidemic. Int J Endocrinol 2017;2017:5308635.
[CROSSREF] [PUBMED] [PMC]
5. Sun X, Shan Z, Teng W. Effects of increased iodine intake on thyroid disorders. Endocrinol Metab (Seoul) 2014;29:240-7.
[CROSSREF] [PUBMED] [PMC]
6. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 2015;3:286-95.
[CROSSREF] [PUBMED]
7. Dong W, Zhang H, Zhang P, Li X, He L, Wang Z, et al. The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization. Med Sci Monit 2013;19:49-53.
[CROSSREF] [PUBMED] [PMC]
8. Blomberg M, Feldt-Rasmussen U, Andersen KK, Kjaer SK. Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation. Int J Cancer 2012;131:2360-6.
[CROSSREF] [PUBMED]
9. Bosetti C, Negri E, Kolonel L, Ron E, Franceschi S, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International). Cancer Causes Control 2002;13:765-75.
[PUBMED]
10. Cao LZ, Peng XD, Xie JP, Yang FH, Wen HL, Li S. The relationship between iodine intake and the risk of thyroid cancer: a meta-analysis. Medicine (Baltimore) 2017;96:e6734.
[PUBMED] [PMC]
11. Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res 2015;8:8.
[CROSSREF] [PUBMED] [PMC]
12. Arija V, Abellana R, Ribot B, Ramon JM. Biases and adjustments in nutritional assessments from dietary questionnaires. Nutr Hosp 2015;31(Suppl 3):113-8.
[PUBMED]
13. Teas J, Pino S, Critchley A, Braverman LE. Variability of iodine content in common commercially available edible seaweeds. Thyroid 2004;14:836-41.
[CROSSREF] [PUBMED]
14. Cho YA, Kong SY, Shin A, Lee J, Lee EK, Lee YJ, et al. Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control study. BMC Cancer 2014;14:873.
[CROSSREF] [PUBMED] [PMC]
15. Lee KE, Park YJ, Cho B, Hwang Y, Choi JY, Kim SJ, et al. Protocol of a thyroid cancer longitudinal study (T-CALOS): a prospective, clinical and epidemiological study in Korea. BMJ Open 2015;5:e007234.
[CROSSREF] [PUBMED] [PMC]
16. Ahn J, Lee JH, Lee J, Baek JY, Song E, Oh HS, et al. Association between urinary sodium levels and iodine status in Korea. Korean J Intern Med 2020;35:392-9.
[CROSSREF] [PUBMED]
18. Munley PH, Bains DS, Bloem WD, Busby RM. Post-traumatic stress disorder and the MMPI-2. J Trauma Stress 1995;8:171-8.
[CROSSREF] [PUBMED]
19. Dasgupta PK, Liu Y, Dyke JV. Iodine nutrition: iodine content of iodized salt in the United States. Environ Sci Technol 2008;42:1315-23.
[CROSSREF] [PUBMED]
21. Chung JH. Update on thyroid hormone levels and thyroid dysfunction in the Korean population based on data from the Korea National Health and Nutrition Examination Survey VI (2013 to 2015). Endocrinol Metab (Seoul) 2020;35:7-13.
[CROSSREF] [PUBMED] [PMC]
22. Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, et al. Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutr 2002;5:915-23.
[CROSSREF] [PUBMED]
23. Kipnis V, Subar AF, Midthune D, Freedman LS, Ballard-Barbash R, Troiano RP, et al. Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol 2003;158:14-21.
[CROSSREF] [PUBMED]
24. Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Andersen S, Rasmussen LB, et al. Estimation of iodine intake from various urinary iodine measurements in population studies. Thyroid 2009;19:1281-6.
[CROSSREF] [PUBMED]
25. Hou D, Xu H, Li P, Liu J, Qian Z. Potential role of iodine excess in papillary thyroid cancer and benign thyroid tumor: a case-control study. Asia Pac J Clin Nutr 2020;29:603-8.
[PUBMED]
26. Lee JH, Song RY, Yi JW, Yu HW, Kwon H, Kim SJ, et al. Case-control study of papillary thyroid carcinoma on urinary and dietary iodine status in South Korea. World J Surg 2018;42:1424-31.
[CROSSREF] [PUBMED]
27. Yan AR, Zhang X, Shen H, Zhou X, Li R, Yuan Z. Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status: a meta-analysis and implications. Endocr J 2019;66:497-514.
[CROSSREF] [PUBMED]
28. Zhao H, Li H, Huang T. High urinary iodine, thyroid autoantibodies, and thyroid-stimulating hormone for papillary thyroid cancer risk. Biol Trace Elem Res 2018;184:317-24.
[CROSSREF] [PUBMED]
29. Kim HJ, Kim NK, Park HK, Byun DW, Suh K, Yoo MH, et al. Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area. Eur J Nutr 2017;56:965-71.
[CROSSREF] [PUBMED]
30. Xiu C, He Q, Zhao HJ, Yuan ZN, Guo LH, Wang FQ, et al. Strong correlation of abnormal serum and urinary iodine levels with papillary thyroid cancer: a case-control study. Biomed Environ Sci 2020;33:62-7.
[PUBMED]
31. Huang F, Cong W, Xiao J, Zhou Y, Gong M, Sun J, et al. Association between excessive chronic iodine exposure and the occurrence of papillary thyroid carcinoma. Oncol Lett 2020;20:189.
[CROSSREF] [PUBMED] [PMC]
32. Zhao H, Li H, Huang T. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer. J Trace Elem Med Biol 2019;53:16-21.
[CROSSREF] [PUBMED]
33. Kim HJ, Park HK, Byun DW, Suh K, Yoo MH, Min YK, et al. Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area. Eur J Nutr 2018;57:809-15.
[CROSSREF] [PUBMED]
34. Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P, et al. Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab 2009;94:1612-7.
[CROSSREF] [PUBMED]
35. Wu X, Lun Y, Jiang H, Gang Q, Xin S, Duan Z, et al. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer. Endocrine 2014;46:554-60.
[CROSSREF] [PUBMED]
36. Lin HY, Tang HY, Shih A, Keating T, Cao G, Davis PJ, et al. Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 2007;72:180-7.
[CROSSREF] [PUBMED]
37. McLeod DS. Thyrotropin in the development and management of differentiated thyroid cancer. Endocrinol Metab Clin North Am 2014;43:367-83.
[CROSSREF] [PUBMED]
38. Lavado-Autric R, Calvo RM, de Mena RM, de Escobar GM, Obregon MJ. Deiodinase activities in thyroids and tissues of iodine-deficient female rats. Endocrinology 2013;154:529-36.
[CROSSREF] [PUBMED]
39. Li N, Jiang Y, Shan Z, Teng W. Prolonged high iodine intake is associated with inhibition of type 2 deiodinase activity in pituitary and elevation of serum thyrotropin levels. Br J Nutr 2012;107:674-82.
[CROSSREF] [PUBMED]
40. Ko YM, Kwon YS, Park YK. An iodine database establishment and iodine intake in Korean adults: based on the 1998~2014 Korea National Health and Nutrition Examination Survey. J Nutr Health 2017;50:624-44.
[CROSSREF]
41. Lipsitz SR, Fitzmaurice GM, Regenbogen SE, Sinha D, Ibrahim JG, Gawande AA. Bias correction for the proportional odds logistic regression model with application to a study of surgical complications. J R Stat Soc Ser C Appl Stat 2013;62:233-50.
[CROSSREF] [PUBMED]
42. Walker DA, Smith TJ. Logistic regression under sparse data conditions. J Mod Appl Stat Methods 2019;18:eP3372.
[CROSSREF]
43. Kuo CL, Duan Y, Grady J. Unconditional or conditional logistic regression model for age-matched case-control data? Front Public Health 2018;6:57.
[CROSSREF] [PUBMED] [PMC]
44. Caldwell KL, Maxwell CB, Makhmudov A, Pino S, Braverman LE, Jones RL, et al. Use of inductively coupled plasma mass spectrometry to measure urinary iodine in NHANES 2000: comparison with previous method. Clin Chem 2003;49(6 Pt 1):1019-21.
[CROSSREF] [PUBMED]
45. Knudsen N, Christiansen E, Brandt-Christensen M, Nygaard B, Perrild H. Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values. Eur J Clin Nutr 2000;54:361-3.
[CROSSREF] [PUBMED]
46. Kim HK, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, et al. Usefulness of iodine/creatinine ratio from spot-urine samples to evaluate the effectiveness of low-iodine diet preparation for radioiodine therapy. Clin Endocrinol (Oxf) 2010;73:114-8.
[PUBMED]